Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-05-04 @ 1:09 AM
Study NCT ID:
NCT07408232
Status:
RECRUITING
Last Update Posted:
2026-02-13
First Post:
2026-02-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)
Sponsor:
Octant, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Retinitis Pigmentosa | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Rhodopsin-associated autosomal dominant Retinitis Pigmentosa | View |
| None | RHO-adRP | View |
| None | Retinitis Pigmentosa | View |
| None | Inherited Retinal Disease | View |
| None | autosomal dominant Retinitis Pigmentosa | View |
| None | Retinitis Pigmentosa 4 | View |
| None | RP4 | View |
| None | RP | View |
| None | Eye Diseases | View |